Skip to main content
Start Project

GHMAP

Class IIb pathway in Saudi Arabia

SFDA market-access overview for class iib devices. Planning intelligence only — not a regulatory determination, approval, or clinical decision support.

Source trackedMiddle East
Timelines, fees, and workflow steps on this page are illustrative market-access planning inputs. They are not legal advice, regulatory approval, or a guarantee of registration, reimbursement, or market entry. Professional review with primary-source verification is required before business use.

Regulatory metrics

Planning ranges for this country and device class. Label every figure as illustrative until sources are verified.

Regulatory pathway metrics for Class IIb in Saudi Arabia
MetricValueStatus
AuthoritySaudi Food and Drug Authority (SFDA)Source tracked
Device classClass IIbExample only
Average timeline~150 days / ~5 months (illustrative)To be verified
Local representative requiredYes — Authorized RepresentativeTo be verified
Government / assessment fee~$3,500 USD (illustrative)Source required

Submission workflow

Step-by-step planning outline. Owners and sequence vary by product evidence and authority questions.

  1. 01

    Confirm SFDA classification

    Map the device to SFDA Class IIb and identify applicable standards.

    Owner: Manufacturer

  2. 02

    Appoint Saudi Authorized Representative

    AR holds the registration and interfaces with SFDA.

    Owner: Manufacturer

  3. 03

    Compile technical file and labeling

    Prepare Arabic/English labeling, QMS evidence, and essential principles documentation.

    Owner: Manufacturer / AR

  4. 04

    Submit SFDA application

    File via the SFDA electronic system and pay applicable fees.

    Owner: AR

  5. 05

    Clear deficiencies and obtain MDMA

    Respond to SFDA questions; after clearance, maintain post-market obligations.

    Owner: AR / Manufacturer

Frequently asked questions

Is SFDA recognition of CE or FDA automatic?
Prior approvals can support the dossier but do not replace SFDA registration. Confirm current reliance pathways with SFDA primary sources.
What does GHMAP Full Country Intelligence include for Saudi Arabia?
A product-specific Decision Report, Evidence & Calculations Workbook, analyst debrief, and one revision round after scope lock — intelligence for planning, not an SFDA approval.

Related market-access pages

Cross-links between pathway pages, country intelligence, and certification primers.

Other Saudi Arabia classes

Country intelligence

Broader market, reimbursement, and procurement context for Saudi Arabia.

Open country profile

Related certifications

Convert planning into a scoped GHMAP engagement

Public pathway pages are general context. Product-specific decisions use request-first market entry packages with written scope lock before research begins.

$5,000 · 15 business days after complete intake and scope lock

Full Country Intelligence

Product-specific market-entry decision for one healthcare or MedTech product in one target country. Includes the Decision Report, Evidence & Calculations Workbook, a 60-minute analyst debrief, and one consolidated revision round.

Request Country Intelligence

$7,500 · 20 business days after complete intake and scope lock

Distributor Search & Qualification

Evidence-based distributor search for one defined MedTech or IVD product in one selected country: 10–15 screened candidates, 10 detailed assessments, and 3–5 recommended for outreach when evidence supports it.

Request Distributor Search

Prefer a shorter briefing first? Request a Regulatory Pathway Brief ($1,800).

Market entry packages

Ready to scope Saudi Arabia?

GHMAP confirms written scope before Country Intelligence or Distributor Search research begins. Payment never auto-approves introductions or workspace access.

Start Country IntelligenceRead disclaimer

Professional review remains part of every GHMAP deliverable.